Online summary
Correction to: Broder MS, Chang EY, Bentley TGK, Juday T, Uy J: Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States. J Med Econ 2011;14:167–78: doi:13696998.2011.554932.
Correction to: Broder MS, Chang EY, Bentley TGK, Juday T, Uy J: Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States. J Med Econ 2011;14:167–78.
On p. 167, the first word of the second sentence of the ‘Results’ section of the abstract should be changed from ‘ATR+r’ to ‘ATV+r’ so that the entire sentence reads as follows:
‘ATV+r patients had lower rates of AIDS (19.08 vs. 20.05 cases/1000 patient-years), OIs (0.44 vs. 0.52), diarrhea (1.27 vs. 6.26), and CHD events (5.44 vs. 5.51), but higher hyperbilirubinemia rates (6.99 vs. 0.25)’.